Junctional epidermolysis bullosa, non-Herlitz type: genes and variants
Explore variant evidence for Junctional epidermolysis bullosa, non-Herlitz type across 5 analyzed proteins (LAMB3, COL17A1, LAMA3, LAMC2, ITGB4). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Junctional epidermolysis bullosa, non-Herlitz type
LAMB3: Laminin subunit beta-3
It contributes the beta3 chain of laminin-332, an essential ligand for hemidesmosomal adhesion at the epidermal basement membrane. Biallelic loss-of-function variants cause junctional epidermolysis bullosa, and selected variants can also cause amelogenesis imperfecta.
2 ClinVar pathogenic / likely pathogenic and 14 uncertain variants in LAMB3 have source records linked to Junctional epidermolysis bullosa, non-Herlitz type. Association strength is not clinical gene validity.
COL17A1: Collagen alpha-1(XVII) chain
It anchors basal keratinocytes to the basement membrane through hemidesmosomes and is essential for stable epidermal adhesion. Biallelic loss-of-function variants cause junctional epidermolysis bullosa, while autoantibodies against the protein cause bullous pemphigoid.
0 ClinVar pathogenic / likely pathogenic and 62 uncertain variants in COL17A1 have source records linked to Junctional epidermolysis bullosa, non-Herlitz type. Association strength is not clinical gene validity.
LAMA3: Laminin subunit alpha-3
It contributes to laminin-332 in epithelial basement membranes, where it supports stable attachment of basal keratinocytes to underlying matrix. Biallelic pathogenic variants can cause junctional epidermolysis bullosa, while some variants cause amelogenesis imperfecta or milder skin disease.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in LAMA3 have source records linked to Junctional epidermolysis bullosa, non-Herlitz type. Association strength is not clinical gene validity.
LAMC2: Laminin subunit gamma-2
It contributes the gamma2 chain of laminin-332 and helps anchor epithelial cells to basement membrane through integrin and dystroglycan interactions. Biallelic pathogenic variants cause junctional epidermolysis bullosa with skin and mucosal fragility.
0 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in LAMC2 have source records linked to Junctional epidermolysis bullosa, non-Herlitz type. Association strength is not clinical gene validity.
ITGB4: Integrin beta-4
It pairs with alpha6 integrin in hemidesmosomes to anchor epithelial cells to laminin-rich basement membranes. Biallelic loss-of-function variants can cause junctional epidermolysis bullosa with pyloric atresia and severe epithelial fragility.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in ITGB4 have source records linked to Junctional epidermolysis bullosa, non-Herlitz type. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Junctional epidermolysis bullosa, non-Herlitz type
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LAMB3 E210K | 210 | Laminin N-terminal | Pathogenic / likely pathogenic (★★) |
| LAMB3 K207Q | 207 | Laminin N-terminal | Pathogenic / likely pathogenic |
Same protein, different disease
- Junctional epidermolysis bullosa also has ClinVar records linked to LAMB3 variants; they fall mostly in different places as the Junctional epidermolysis bullosa, non-Herlitz type variants (4 pathogenic / likely pathogenic).
Diseases related to Junctional epidermolysis bullosa, non-Herlitz type
- Junctional epidermolysis bullosa, also linked to COL17A1, ITGB4, LAMA3, LAMB3 and 1 more
- Junctional epidermolysis bullosa gravis of Herlitz, also linked to LAMA3, LAMB3 and LAMC2
- Amelogenesis imperfecta, also linked to COL17A1 and LAMB3
- Junctional epidermolysis bullosa - pyloric atresia, also linked to ITGB4
- Fetal anomalies with a likely genetic cause, also linked to ITGB4
- Epidermolysis bullosa, junctional 5A, intermediate, also linked to ITGB4
Frequently asked questions
Which genes have records linked to Junctional epidermolysis bullosa, non-Herlitz type?
This view contains 5 analyzed proteins: LAMB3, COL17A1, LAMA3, LAMC2, ITGB4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 140 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center